ProfileGDS4718 / 205168_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 64% 70% 92% 67% 65% 59% 64% 70% 67% 63% 70% 66% 64% 63% 58% 70% 66% 67% 60% 74% 69% 66% 65% 71% 66% 61% 70% 64% 68% 54% 59% 76% 66% 64% 73% 64% 62% 70% 65% 96% 66% 63% 82% 61% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.4340464
GSM549102patient 115, normal, homogenized [OPG study]6.8226170
GSM549104patient 119, normal, homogenized [OPG study]9.6327592
GSM549108patient 138, normal, homogenized [OPG study]6.5822567
GSM549119patient 077, normal, homogenized [OPG study]6.4699965
GSM549133patient 032, cancer, homogenized [OPG study]6.0496559
GSM549139patient 042, cancer, homogenized [OPG study]6.4460164
GSM549099patient 107, normal, homogenized [OPG study]6.8542170
GSM549109patient 139, normal, homogenized [OPG study]6.657467
GSM549110patient 046, normal, homogenized [OPG study]6.3443863
GSM549114patient 063, normal, homogenized [OPG study]6.8305970
GSM549122patient 082, normal, homogenized [OPG study]6.5642866
GSM549134patient 033, cancer, homogenized [OPG study]6.3539664
GSM549136patient 036, cancer, homogenized [OPG study]6.3146363
GSM549140patient 044, cancer, homogenized [OPG study]5.9870558
GSM549111patient 047, normal, homogenized [OPG study]6.9328570
GSM549113patient 057, normal, homogenized [OPG study]6.557766
GSM549132patient 031, cancer, homogenized [OPG study]6.6252567
GSM549137patient 038, cancer, homogenized [OPG study]6.1101760
GSM549142patient 047, cancer, homogenized [OPG study]7.1595674
GSM549100patient 110, normal, homogenized [OPG study]6.7460569
GSM549107patient 135, normal, homogenized [OPG study]6.557766
GSM549115patient 068, normal, homogenized [OPG study]6.4999965
GSM549116patient 072, normal, homogenized [OPG study]6.9541271
GSM549120patient 078, normal, homogenized [OPG study]6.5761766
GSM549131patient 030, cancer, homogenized [OPG study]6.2106161
GSM549118patient 074, normal, homogenized [OPG study]6.8946270
GSM549129patient 027, cancer, homogenized [OPG study]6.4179964
GSM549123patient 088, normal, homogenized [OPG study]6.6760768
GSM549124patient 006, cancer, homogenized [OPG study]5.7879554
GSM549126patient 015, cancer, homogenized [OPG study]6.0329259
GSM549128patient 025, cancer, homogenized [OPG study]7.5142776
GSM549103patient 117, normal, homogenized [OPG study]6.5232166
GSM549117patient 073, normal, homogenized [OPG study]6.343364
GSM549138patient 041, cancer, homogenized [OPG study]7.1677473
GSM549141patient 045, cancer, homogenized [OPG study]6.4141864
GSM549130patient 028, cancer, homogenized [OPG study]6.2293962
GSM549101patient 111, normal, homogenized [OPG study]6.8626470
GSM549105patient 128, normal, homogenized [OPG study]6.5072365
GSM549106patient 134, normal, homogenized [OPG study]10.742796
GSM549112patient 048, normal, homogenized [OPG study]6.5460866
GSM549125patient 011, cancer, homogenized [OPG study]6.3558363
GSM549127patient 024, cancer, homogenized [OPG study]8.0601982
GSM549135patient 035, cancer, homogenized [OPG study]6.1882461